Amplia Therapeutics Limited announced that Mr. Tim Luscombe will replace Mr. Hamish George as Chief Financial Officer (CFO) of the Company. Mr. Luscombe is a highly experienced Chartered Accountant who holds a Bachelor of Commerce from the University of Melbourne and a Certificate in Governance Practice from the Governance Institute of Australia. He is a Director at Bio101 Financial Advisory and has been working with Amplia in a senior accounting capacity over the last two years.